1222037

Kevin P. O'Brien, MD — FEI 3027402412

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 20, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Denver, CO (United States)

Additional Details

Clinical Investigator (CI)